Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer
Charles N. Landen, Chunhua Lu, Liz Y. Han, Karen T. Coffman, Elizabeth Bruckheimer, Jyotsnabaran Halder, Lingegowda S. Mangala, William M. Merritt, Yvonne G. Lin, Changhou Gao, Rosemarie Schmandt, Aparna A. Kamat, Yang Li, Premal Thaker, David M. Gershenson, Nila U. Parikh, Gary E. Gallick, Michael S. Kinch, Anil K. Sood
Dive into the research topics of 'Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer'. Together they form a unique fingerprint.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science